Digital The benefits of adopting a truly digital mindset for pharmac... Historically, the pharmaceutical industry has been in the laggard phase when it comes to digital adoption.
Digital The precision element at the heart of digital transformation On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul.
Digital AI in drug development: A reality check In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery
Digital Relevance and impact: Connecting with HCPs in the digital ag... What’s the best way to influence physician behaviour? This is the pharmaceutical industry’s billion-dollar question.
Digital Combatting longstanding challenges in rare disease detection... Approximately 350 million people are living with up to 8,000 rare diseases worldwide.
Digital Epiphany moments in an industry starved of insights Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
